Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics

Merkel cell carcinoma is an ultra-rare cutaneous neuroendocrine cancer for which approved treatment options are lacking. To better understand potential actionability, the genomic landscape of Merkel cell cancers was assessed. The molecular aberrations in 17 patients with Merkel cell carcinoma were,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Philip R., Tomson, Brett N., Elkin, Sheryl K., Marchlik, Erica, Carter, Jennifer L., Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029639/
https://www.ncbi.nlm.nih.gov/pubmed/26981779
http://dx.doi.org/10.18632/oncotarget.8032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029639/
https://www.ncbi.nlm.nih.gov/pubmed/26981779
http://dx.doi.org/10.18632/oncotarget.8032

Ejemplares similares